Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

Resources & Support

References

First Author
Di Carlo, S
Title
GM-CSF suppresses antioxidant signaling and drives IL-1β secretion through NRF2 downregulation.
Citation
EMBO reports; 2022 Aug 3; 23(8) pge54226
PubMed Id
35695080
Show Usages
Product Cited
Cross-Reactivity
Applications
210-10
Mouse
in vitro
300-25
Mouse
in vitro
First Author
Zhang, Y
Title
MED1 Deficiency in Macrophages Accelerates Intimal Hyperplasia via ROS Generation and Inflammation.
Citation
Oxidative medicine and cellular longevity; 2021; 2021 pg3010577
PubMed Id
34853629
Show Usages
Product Cited
Cross-Reactivity
Applications
300-25
Mouse
in vitro
250-10
Mouse
in vitro
First Author
Bae, S
Title
MYC-mediated early glycolysis negatively regulates proinflammatory responses by controlling IRF4 in inflammatory macrophages.
Citation
Cell reports; 2021 Jun 15; 35(11) pg109264
PubMed Id
34133930
Show Usages
Product Cited
Cross-Reactivity
Applications
300-25
Mouse
in vitro
First Author
Olson, G S
Title
Type I interferon decreases macrophage energy metabolism during mycobacterial infection.
Citation
Cell reports; 2021 Jun 1; 35(9) pg109195
PubMed Id
34077724
Show Usages
Product Cited
Cross-Reactivity
Applications
300-25
Mouse
in vitro
First Author
Murray, J B
Title
Activation of (pro)renin by (pro)renin receptor in extracellular vesicles from osteoclasts
Citation
Scientific reports; 2021 Apr 28; 11(1) pg9214
PubMed Id
33911158
Show Usages
Product Cited
Cross-Reactivity
Applications
300-25
Mouse
in vitro
First Author
Wei, Z
Title
Mutations in Profilin 1 Cause Early-Onset Paget's Disease of Bone With Giant Cell Tumors.
Citation
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research; 2021 Jun; 36(6) pg1088-1103
PubMed Id
33599011
Show Usages
Product Cited
Cross-Reactivity
Applications
300-25
Human
in vitro
310-01
Human
in vitro
300-25
Mouse
in vitro
310-01
Mouse
in vitro
First Author
Sadvakassova, G
Title
Active hematopoiesis triggers exosomal release of PRDX2 that promotes osteoclast formation.
Citation
Physiological reports; 2021 Feb; 9(3) pge14745
PubMed Id
33587325
Show Usages
Product Cited
Cross-Reactivity
Applications
300-25
Mouse
in vitro
First Author
Sapra, L
Title
Lactobacillus rhamnosus attenuates bone loss and maintains bone health by skewing Treg-Th17 cell balance in Ovx mice.
Citation
Scientific reports; 2021 Jan 19; 11(1) pg1807
PubMed Id
33469043
Show Usages
Product Cited
Cross-Reactivity
Applications
300-25
Mouse
in vitro
310-01
Mouse
in vitro
AF-100-21C
Mouse
in vitro
AF-212-12
Mouse
in vitro
AF-216-16
Mouse
in vitro
200-23
Mouse
in vitro
First Author
Albers, G J
Title
IRF5 regulates airway macrophage metabolic responses.
Citation
Clinical and experimental immunology; 2021 Apr; 204(1) pg134-143
PubMed Id
33423291
Show Usages
Product Cited
Cross-Reactivity
Applications
300-25
Mouse
in vitro
First Author
Andreev, D
Title
Osteocyte necrosis triggers osteoclast-mediated bone loss through macrophage-inducible C-type lectin.
Citation
The Journal of clinical investigation; 2020 Sep 1; 130(9) pg4811-4830
PubMed Id
32773408
Show Usages
Product Cited
Cross-Reactivity
Applications
300-25
Mouse
in vitro
310-01
Mouse
in vitro
100-21C
Mouse
in vitro
315-02
Mouse
in vitro
315-11
Mouse
in vitro
showing 10 of 75
Show More